SynthesisEndocrine2014

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature.

Carlo B Giorda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.